The Pharmacy Times® Eye Care Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of eye diseases and conditions, including age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma.
April 10th 2024
In a review, investigators focused on ranibizumab (Lucentis; Genentech), aflibercept (Eylea; Regeneron), and bevacizumab (Avastin; Genentech) as growth opportunities in the biosimilar space.
Addressing Unmet Needs and Treatment Gaps in the Clinical Management of Neovascular Age-Related Macular Degeneration: Practical Strategies for Pharmacists in Specialty and Man...
1.5 Credits / Ophthalmology/Optometry
View More
Management of Neuromyelitis Optica Spectrum Disorder: Expert Insights and Updates for Pharmacists, featuring a Patient Perspective
1.5 Credits / Ophthalmology/Optometry
View More
The Promising Role of Novel Targeted Therapies in Addressing Clinical and Economic Burdens in Diabetic Macular Edema
1.5 Credits / Ophthalmology/Optometry
View More
Geographic Atrophy: The Role of the Specialty Pharmacist in Introducing Disease-Specific Therapies
1.5 Credits / Ophthalmology/Optometry
View More
Improving Outcomes and Quality of Care in Age-Related Macular Degeneration and Diabetic Macular Edema: Patient-Centered Strategies in Managed Care
3.0 Credits / Ophthalmology/Optometry
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
AMD and DME: Addressing the Disease Burden, Treatment Challenges, and Opportunities for Improved Management
1.0 Credit / Ophthalmology/Optometry
View More
AMD and DME: Exploring New and Emerging Therapies in the Treatment Landscape
1.0 Credit / Ophthalmology/Optometry
View More
AMD and DME: Highlighting the Role of the Pharmacist in Patient Education and Counseling
1.0 Credit / Ophthalmology/Optometry
View More
Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars
1.0 Credit / Ophthalmology/Optometry
View More
Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Prevention (Pharmacist Credit)
2.0 Credits / Ophthalmology/Optometry
View More
Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Prevention (Pharmacy Technician Credit)
2.0 Credits / Ophthalmology/Optometry
View More
Assessing Utility of Anti-Vascular Endothelial Growth Factor Therapies in Retinal Disease: The Pharmacist’s Role From Access to Adherence, featuring a Patient Perspective
1.5 Credits / Ophthalmology/Optometry
View More
The Evolving Treatment Paradigm of Demodex Blepharitis: Considerations for Pharmacists (Pharmacy Technician Credit)
1.0 Credits / Ophthalmology/Optometry, Dermatology
View More
The Evolving Treatment Paradigm of Demodex Blepharitis: Considerations for Pharmacists (Pharmacist Credit)
1.0 Credits / Ophthalmology/Optometry, Dermatology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
FDA Approves Hepzato Kit for Liver-Directed Treatment of Metastatic Uveal Melanoma
August 16th 2023Melphalan/hepatic delivery system (Hepzato Kit; Delcath Systems Inc) is currently the only liver-directed therapy approved by the FDA for the treatment of netastatic uveal melanoma and percutaneous hepatic perfusion.
Read More